CCL4

Across TCGA pan-cancer cohorts, CCL4 Mutation is linked to patient survival in 2 of 34 cancer types, making it a survival-associated CCL4 data layer compared with 20 for mass-spec protein.

The strongest signal is observed in lung squamous cell carcinoma (LUSC), where higher CCL4 Mutation is associated with worse overall survival. In most high-consensus cancer types, elevated CCL4 expression acts as an unfavorable survival marker, although some lineages such as UCEC show a favorable association.

LUSC and UCEC are the cancer types where CCL4 Mutation most reproducibly stratifies survival.

Mutation survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
LUSC	OS	Median	All	0.120	0.762	<.001	12	view →
UCEC	DFS	Median	All	1.000	0.626	.048	2	view →

Pink = unfavorable, green = favorable. Showing the 2 strongest of 2 lineages.

CCL4–LUSC (OS)

Open the LUSC breakdown →